Baxter

Devices & Diagnostics

New potential source of hospital infections? Drug-mixing robots

Researchers have identified a potential threat that could result in hospital-acquired infections — bacterial contamination of automated pharmacy robots that mix intravenous medications. In a paper published in Infection Control and Hospital Epidemiology, researchers said that their report was the first to their knowledge that detailed a pharmacy robot being contaminated with bacteria and the […]

Devices & Diagnostics

Baxter Ventures will invest $200 million in early-stage companies

Baxter International Inc. (NYSE: BAX) put aside $200 million in equity to invest in early-stage companies that “complement” its portfolio. The newly established ” Baxter Ventures will invest globally and focus on innovative technologies with sustainable long-term growth” under the watch of the Deerfield, Ill.-based company’s chief scientific officer Norbert Riedel, according to a press release. […]

MedCity Influencers

Baxter selling generic injectables business to U.K. firm

Baxter International Inc. (NYSE:BAX) is planning to offload its U.S.-based generic injectables business to British drug firm Hikma Pharmaceuticals PLC (LSE:HIK). The deal is worth about $112 million to the Deerfield, Illinois-based company, according to a statement. The agreement is comprised of Hikma acquisition of Baxter’s injectable products in vials and ampules, which are marketed […]

News

Some hospitals make huge profits (Morning Read)

The average American hospital barely breaks even, according to Forbes' first survey of America's most profitable hospitals. But the most profitable hospital in the country -- 235-bed Flowers Medical Center in Dothan, Alabama -- recorded a 53 percent operating margin and belongs to the for-profit Community Health Systems (NYSE: CYH) chain in Brentwood, Tennessee.